These MCF-7/HER2Δ16 cells also present decreased expression of miR-342, which was shown to regulate expression of genes involved in breast tumor cell cycle progression, such as cyclin B1, p53, and breast cancer 1 (BRCA1) [87]. Here, BRCA1 is linked to breast neoplasm.